Clinical study on the efficacy of flutamide for androgen dependent dilated cardiomyopathy
Not Applicable
- Conditions
- Dilated cardiomyopathy
- Registration Number
- JPRN-jRCTs051180123
- Lead Sponsor
- Onoue Kenji
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 2
Inclusion Criteria
1. Patients with androgen dependent familial dilated cardiomyopathy.
2. Patients who are sufficiently understood that standard treatments indicate no adequate therapeutic efficacy.
3. Patients who are sufficiently understood that the efficacy and safety of flutamide was not yet fully secured.
4. Patients who are able to provide signed informed consent.
Exclusion Criteria
1. Patients with a history of hypersensitivity to flutamide.
2. Patients with hepatic impairment.
3. Patients who are not able to provide signed informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method